HemoShear
is a Virginia-based biotechnology company that researches and develops novel therapeutics for the treatment of liver and metabolic disorders... Read moreHemoShear
is a Virginia-based biotechnology company that researches and develops novel therapeutics for the treatment of liver and metabolic disorders... Read more
News
Nov 16, 2023
Citybizlist
HemoShear: Drug Developer HemoShear Therapeutics Secures $3.5 Million Debt
May 18, 2023
PR Newswire
Press Release: HemoShear : HemoShear Attends Piper Sandler Conference
Oct 18, 2022
Markets Insider
HemoShear: HemoShear Therapeutics to Participate in SVB Leerink Securities Biopharma Private Company Connect
Sep 21, 2022
FirstWord Pharma
HemoShear: HemoShear Therapeutics Advancing Novel Modulators Against Second Target for Horizon Therapeutics' Gout Discovery Pipeline
Sep 21, 2022
Seeking Alpha
HemoShear: Horizon pays HemoShear milestone payment under pact to develop gout therapies
Aug 10, 2022
BioSpace
HemoShear: HemoShear Develops New Human Tissue-Based Model of Rare Liver Disease Under Research Collaboration with Takeda
Jun 17, 2022
HemoShear Vimeo Channel
HemoShear posted a video "HemoShear OAA and PAF Webinar April 2021" on VIMEO
Jun 08, 2022
HemoShear Vimeo Channel
HemoShear posted a video "HemoShear Poster Talk" on VIMEO
Jun 07, 2022
PR Newswire
Press Release: HemoShear : OpenBench Assigns Two AI-Discovered Series to HemoShear Therapeutics
Dec 15, 2021
Citybizlist
HemoShear: HemoShear Therapeutics Appoints Patrick Horn, MD, PhD, CMO
